Ksilometazolinklorid/ipratropijev bromid Acino 0,5 mg/ml + 0,6 mg/ml sprej za nos, otopina
| Name | Ksilometazolinklorid/ipratropijev bromid Acino 0,5 mg/ml + 0,6 mg/ml sprej za nos, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-735131331 |
| Active Substance | ksilometazolinklorid ipratropijev bromid hidrat |
| Composition | 1 ml otopine sadrži 0,5 mg ksilometazolinklorida i 0,6 mg ipratropijevog bromida u obliku ipratropijevog bromida hidrata |
| Pharmaceutical Form | sprej za nos, otopina |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Hrvatska |
| Marketing Authorisation Holder | Acino France SAS, Centre Specialité Pharmaceutiques (CSP), 76-78 avenue du Midi CS 30077, Cournon d'Auvergne Cedex, Francuska |
| Marketing Authorisation Date | 03.03.2022 |
| MA Period of Validity | 03.03.2027 |
| Classification Number | UP/I-530-09/20-01/25 |
| Registration Number | 381-12-01/70-22-06 |
| Prescription | na recept |
| Type of prescription | neponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | R01AB06 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
